Live
- Congress Clinches Landmark Victory in Shiggaavi By-Elections
- Vidhu Vinod Chopra embraces realism
- Maharashtra election result reflects people's trust in PM Modi: Chandrababu Naidu
- Maharashtra has rejected Rahul Gandhi & Congress: Tamilisai Soundararajan
- Roads blocked with containers, army called in as Pakistan seals capital Islamabad ahead of PTI protest
- ISL 2024-25: NorthEast United forward Alaaeddine Ajaraie named Player of the Month
- MahaYuti’s landslide win a major boost to make Maharashtra a $1 trillion economy
- Regional parties will continue to be future of Indian politics, says BRS
- Most Americans not aware that alcohol ups cancer risk: Survey
- Bengal bypolls: Trinamool Congress sweeps up all six Assembly constituencies, Mamata thanks voters (4th Lead)
Sun Pharma drops 7.5 per cent on Sebi report
Highlights
Shares of Sun Pharmaceutical Monday dived 75 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters The companys shares fell 752 per cent to end at Rs 45530 apiece on the BSE
​New Delhi: Shares of Sun Pharmaceutical Monday dived 7.5 per cent after reports that markets regulator Sebi may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters. The company's shares fell 7.52 per cent to end at Rs 455.30 apiece on the BSE.
During the day, the stock declined 10.22 per cent to Rs 441.95. On the NSE, the scrip of the company slumped by 7.53 per cent to close at Rs 455.50. In terms of volume, over 48 lakh shares were traded on the BSE, while over 6 crore units changed hands on the NSE.
Next Story
ADVERTISEMENT
